The NxPs led to high-efficiency editing, tumor-selective suppression of IL30 signaling pathways and remodeling of the intratumoral immune cell context, resulting in substantial tumor growth inhibition and improved survival without evident toxicity. The gene discussed is IL27; the disease is neoplasm.